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Objective: Hospital-acquired infections (HAI) are a global problem and a major
public health concern in hospitals throughout the world. Quantification of HAI is
needed in developing countries; hence we describe the results of a 2-year
surveillance data in a tertiary hospital in Nigeria.
Methodology: This study is a 2-year review using secondary data collected at a
tertiary referral center in northwestern Nigeria. The data was collected using
surveillance forms modeled based on the Centre for Disease Control (CDC)
protocol. Descriptive statistics were used to present results as frequencies and
percentages..e00720
vier Ltd. This is an open access article under the CC BY-NC-ND license
y-nc-nd/4.0/).
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prevalence of 6.3%. The mean age of the patients was 35.98 years (15.92). Males
constituted 281 (54.2%). UTI 223 (43.1%) was the most prevalent HAI. Overall,
E. coli 207 (40.0%) was the most frequent isolates followed by P. aerugenosa
80 (15.4%). There was a high prevalence of cloxacillin resistant S. aureus (67.9%)
and gram-negative rods resistant to third-generation cephalosporins. Trimethoprim-
sulfamethoxazole resistance across the board was more than 90%.
Conclusion: There is a high burden of HAI especially UTI in our hospital with
resistance to commonly used antibiotics documented.
Keywords: Public health, Infectious disease
1. Introduction
Hospital-acquired infections (HAI) are a global problem and a major public health
concern in hospitals throughout the world. Mostly caused by multi drug resistance
(MDR) organisms, HAI significantly contributes to increased morbidity, mortality,
and hospital cost [1, 2, 3]. HAI is also a major global safety concern for both patients
and health-care professionals [4, 5].
In developed countries, HAI rates of 5% to 15%, sometimes up to 50%, have been
reported among hospitalized patients in the regular wards and intensive care units
(ICUs) respectively [6, 7]. In developing countries, the problem is likely much
higher, and yet, the magnitude of the problem remains underestimated or even un-
known largely because HAI diagnosis is complex and surveillance activities which
requires expertise and resources, are lacking in most of these countries [8]. Further-
more, infection control practices remain rudimentary as most hospitals lack effective
infection control programs and trained professionals [9].
Quantification of HAI is needed through an effective surveillance system in devel-
oping countries to understand the burden and help to justify resources dedicated
to infection control. We describe the results of a 2-year surveillance data including
bacterial etiologic agent and antimicrobial resistance in a major tertiary hospital in
northwestern Nigeria.2. Materials and methods
This study is a 2-year review using secondary data collected from January 2012 to
January 2014 at a tertiary referral center in northwestern Nigeria. The hospital has a
total bed capacity of 500 and provides a tertiary level care to a mixed population of
patient comprising urban, semi-urban and rural population It has several clinical
departments including Medicine, Surgery, Pediatrics, Obstetrics and Gynecology
with the full support of well-equipped laboratories. It serves as a referral centeron.2018.e00720
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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over thirty five million people. Since the establishment of the hospital’s infection
control committee, the HAI surveillance team comprising of trained infection con-
trol nurses take a daily round to take a point prevalence of HAI (defined as onset of
infection after 48 hours of admission which was not present and without evidence
of incubation at the time of admission to the hospital) in all the wards of the hos-
pital. Data was collected using modified surveillance forms modeled after the
Centre for Disease Control (CDC) protocol [10] which contained essential identi-
fying data like age, sex, hospital identification number, wards or location within the
hospital, service, and date of admission. Others are the date of infection, site of
infection and the organism(s) isolated from the specimen and antimicrobial suscep-
tibility pattern of the isolates. These are further analyzed quarterly to generate data
for the overall frequency and distribution pattern of HAI in our hospital. A record
of this data sheets from January 2012 to January 2014 was collected from the com-
mittee, and the data was extracted using a questionnaire which was administered
retrospectively. Infections developing after discharge were not captured and acute
care units (Emergency units and Labour wards) were also excluded. Patients with
clinical record of suspected HAI without microbiologic confirmation were
excluded. Patients who were on admission not because of an infection and have
stayed on admission for at least 48 hours were considered as the total number of
admissions during the study period.
Relevant specimen(s) depending on the HAI clinical syndrome were collected
appropriately and delivered to the laboratory. Standard bacteriologic methods using
conventional culture media including MacConkey agar, blood agar and chocolate
agar incubated overnight under different necessary conditions were employed to
isolate causative pathogens. Depending on the gram staining reaction, differential
biochemical tests such as catalase test or oxidase test and other phenotypic charac-
teristics such as, colony color, pigment production, odor and motility were used to
identify the isolate(s). In line with Clinical and Laboratory Standards Institute
(CLSI) guidelines [11], isolates were tested against a full spectrum of antibiotic
groups using disk diffusion technique.
The information from the questionnaires was initially entered into excel sheet and
subsequently exported and analyzed using STATA SE version 12.1 (Stata Corp.,
College Station, TX). Descriptive statistics were used to present results as fre-
quencies and percentages. Chi-square tests and relative risks were computed to
describe associations. A p-value less than 0.05 was considered statistically
significant.
Ethical approval to conduct the study was obtained from the ethics committee of the
Hospital with reference number NHREC/21/08/2008/AKTH/EC/1994.on.2018.e00720
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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A total of 518 patients developed HAI out of 8216 patients who were on admissions
during the study period, giving an overall prevalence of 6.3%. The mean age of the
patients was 35.98 years (15.92) with males constituting 281 (54.2%, Table 1).
Majority of the patients were on admission following surgery 103 (19.9%), followed
by diabetic complications 61 (11.8%) and chronic kidney disease (CKD) 54 (10.4%).
Table 1, shows the distribution of HAI syndrome, with urinary tract infection (UTI)
223 (43.1%) been the most prevalent followed by soft tissue infection 177 (34.2%)
and surgical site infections (SSI) 94 (18.1%). The frequency of the infections in
each of the ward is shown in Table 2, ICU recorded the highest prevalence followed
by surgical ward, while paediatric ward had the least prevalence. OverallTable 1. Demographic and clinical characteristics of the patients.
Variables n [ 518
Age (Mean) 35.98 years (15.92)
Gender N (%)
Male 281 (54.2)
Female 237 (45.8)
Admission diagnoses N (%)
Diabetes 61 (11.8)
Chronic kidney disease (CKD) 54 (10.4)
Human immunodeficiency virus (HIV)
infection
28 (5.4)
Cerebrovascular disease (CVD) 37 (7.1)
Chronic heart disease 19 (3.7)
Post-surgery 103 (19.9)
Solid tumours 36 (6.9)
Leukaemias 10 (1.9)
Trauma 37 (7.1)
Burns 31 (6.0)
Renal transplants 4 (0.8)
Pre-term 41 (7.9)
Protein energy malnutrition (PEM) 13 (2.5)
Tuberculosis 26 (5.0)
Others 18 (3.5)
Site of hospital-acquired infection N (%)
Soft tissue 177 (34.2%)
Nosocomial pneumonia 14 (2.7%)
Blood stream infection 10 (1.9%)
Urinary tract infection 223 (43.1%)
Surgical site infection (SSI) 94 (18.1%)
on.2018.e00720
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Table 2. Prevalence of HAI by hospital ward.
Ward Number of patients Number of infections (%)
Surgical ward 2602 236 (9.1)
Medical ward 2714 180 (6.6)
Obstetrics and gynaecology 1360 45 (3.3)
Paediatrics ward 1087 27 (2.5)
Intensive care unit 202 23 (11.4)
Special care baby unit 250 7 (2.8)
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Pseudomonas aeruginosa 80 (15.4%) while Staphylococcus aureus and Proteus
spp. were isolated with equal frequency 78 (15.1%), (Table 3). Among patients
with nosocomial pneumonia and blood stream infection, K. pneumoniae and E.
coli were the most frequent isolates respectively. S. aureus was the commonest iso-
lates in patients with soft tissue infection and surgical site infection (Table 3). The
highest number of blood stream infections were recorded in the intensive care unit
(ICU) followed by the special care baby unit (SCBU), while most of the cases of
nosocomial pneumonia were seen in the medical ward. Furthermore, soft tissue in-
fections and SSI were most frequent in the surgical ward (Table 4). Table 5 shows
the distribution of the isolates according to the site of infection, the majority of the P.
aeruginosa isolates 3 (21.4%) were in patients with hospital-acquired pneumonia,
while, 69 (49.4%) of the S. aureus isolates was in patients with surgical site infection
(SSI) and soft tissue infection combined. The only 2 enterococcal isolates were in
patients with UTI and one case of Streptococcus pneumoniae SSI was seen.
Tables 6 and 7 shows the resistance pattern of gram negative and gram positive iso-
lates respectively. The highest proportions of resistance among the Enterobacteri-
aceae isolates were observed against amoxicillin/clavulanic acid and trimethoprim-
sulfamethoxazole. Resistance to trimethoprim-sulfamethoxazole across the boardTable 3. Distribution of the identified nosocomial pathogens.
Isolates n [ 518 N (%)
Proteus spp. 78 (15.1)
Pseudomonas aeruginosa 80 (15.4)
Staphylococcus aureus 78 (15.1)
Klebsiella pneumonia 65 (12.5)
Escherichia coli 207 (40.0)
Citrobacter freundii 1 (0.2)
Streptococcus pyogenes 5 (1.0)
Streptococcus pneumonia 2 (0.4)
Enterococcus spp. 2 (0.4)
on.2018.e00720
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Table 4. Infection site by ward.
Ward n (%) of infection
Soft tissue
n [ 177
Pneumonia
n [ 14
Blood stream
n [ 10
UTI n [ 223 SSI n [ 94
Surgical ward 98 (55.4) 1 (7.1) 1 (10.0) 62 (27.8) 74 (78.7)
Medical ward 47 (26.6) 10 (71.4) 2 (20.0) 121 (54.3) 0 (0.0)
Obstetrics and
Gynecology
15 (8.5) 2 (14.3) 0 (0.0) 12 (5.4) 16 (17.0)
Pediatrics ward 9 (5.1) 1 (7.1) 0 (0.0) 17 (7.6) 0 (0.0)
ICU 7 (4.0) 0 (0.0) 4 (40.0) 11 (4.9) 1 (1.1)
SCBU 1 (0.6) 0 (0.0) 3 (30.0) 0 (0.0) 3 (3.2)
UTI- Urinary Tract Infection, SSI- Surgical Site Infection, ICU- Intensive Care Unit, SCBU- Special
Care Baby Unit.
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rate of 21.3% and 28.7% respectively across the Enterobacteriaceae isolates.
Although fewer isolates was tested against colistin and meropenem, sensitivity
was 100% among gram-negative bacilli. Resistance to cloxacillin among the S.
aureus isolates was 67.2%, while resistance to ciprofloxacin, chloramphenicol,
and clindamycin was 11 (15.1%), 13 (18.1%) and 13 (20.6%) respectively.4. Discussion
The overall prevalence of HAI in this study was 6.3%, with the ICU having the high-
est prevalence. Urinary tract infection was the commonest infection seen followed
by soft tissue infection, while overall E. coli was the most frequent isolates.Table 5. Frequency of the isolates by infection site.
Isolates n (%) of infection
Soft tissue
n [ 177
pneumonia
n [ 14
Blood stream
n [ 10
UTI n [ 223 SSI n [ 94
Proteus spp. 32 (18.1) 0 (0.0) 0 (0.0) 33 (14.8) 13 (13.8)
P. aeruginosa 28 (15.8) 3 (21.4) 1 (10.0) 36 (16.1) 12 (12.8)
S. aureus 48 (27.1) 1 (7.1) 2 (20.0) 6 (2.7) 21 (22.3)
K. pneumonia 21 (11.9) 5 (35.7) 1 (10.0) 33 (14.8) 5 (5.3)
E. coli 46 (26.0) 2 (14.3) 3 (30.0) 114 (51.1) 42 (44.7)
C. freundii 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.4) 0 (0.0)
S. pyogenes 0 (0.0) 3 (21.4) 2 (20.0) 0 (0.0) 0 (0.0)
S. pneumonia 0 (0.0) 0 (0.0) 1 (10.0) 0 (0.0) 1 (1.1)
Enterococcus spp. 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.9) 0 (0.0)
SSI- Surgical Site Infection, UTI- Urinary Tract Infection.
on.2018.e00720
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Table 6. Resistance patterns of gram negative bacterial isolates to main antimicrobial agents.
Isolates Number of isolates resistant/number of isolates tested (%)
Chloramphenicol Gentamicin Ceftriaxone Ciprofloxacin TPM/SMX Ceftazidime AMC/CLV Meropenem Colistin
Proteus spp. 15/67 (22.4) 21/66 (31.8) 37/63 (58.7) 13/67 (19.4) 56/65 (86.2) 34/60 (56.7) 48/70 (68.6) 0/15 (0.0) 0/24 (0.0)
P. aeruginosa 7/16 (43.8) 10/54 (18.5) N 19/75 (25.3) N 2/21 (9.5) N 0/6 (0.0) 0/25 (0.0)
K. pneumonia 11/56 (19.6) 21/63 (33.3) 46/65 (70.8) 10/60 (16.8) 58/63 (92.1) 19/34 (55.9) 48/64 (75.0) 0/9 (0.0) 0/8 (0.0)
E. coli 23/110 (20.9) 58/203 (28.6) 156/207 (75.4) 43/198 (21.7) 81/86 (94.2) 35/61 (57.3) 161/202 (79.7) 0/21 (0.0) 0/50 (0.0)
C. freundii N 1/1 (100.0) N N 0/1 (0.0) 1/1 (100.0) 0/1 (0.0)
N- Not tested, TPM/SMX- Trimethoprim-Sulphamethoxazole, AMC/CLV- Amoxycillin-Clavulanic Acid.
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Table 7. Resistance patterns of gram positive bacterial isolates to main antimicrobial agents.
Isolates Number of isolates resistant/number of isolates tested (%)
Chloramphenicol Gentamicin Ceftriaxone Ciprofloxacin TPM/SMX AMC/CLV Amoxycillin Cloxacillin Clindamycin
S. aureus 13/72 (18.1) 26/71 (36.6) 61/78 (78.2) 11/73 (15.1) 75/78 (96.2) 45/66 (68.1) 52/73 (71.2) 53/78 (67.9) 13/63 (20.6)
S. pyogenes 0/2 (0.0) N 0/5 (0.0) 0/2 (0.0) N 0/5 (0.0) 0/5 (0.0) 0/5 (0.0) 0/1 (0.0)
S. pneumonia 0/2 (0.0) 0/2 (0.0) 0/2 (0.0) 1/2 (0.0) 2/2 (100.0) 0/2 (0.0) 0/2 (0.0) 1/1 (100.0) 0/1 (0.0)
Enterococcus spp. N 0/2 (0.0) N 1/2 (50.0) 2/2 (100.0) N 0/2 (0.0) N N
N- Not tested, TPM/SMX- Trimethoprim-Sulphamethoxazole, AMC/CLV- Amoxycillin-Clavulanic Acid.
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isolate. The high rate of resistance to commonly used antibiotics was documented.
The HAI prevalence of of 6.3% reported in this study is higher than 2.5%e3.5% re-
ported by retrospective studies of HAI in southwestern Nigeria over the period of
1995e2009 [12, 13, 14] but much lower than the 34-14% and 17.9% reported in
Uganda and Tunisia respectively [14, 15]. This high discrepancy may be due to dif-
ferences in the methodologies adopted, hospitals infection control prevention (ICP)
and the time gap between these studies. We found the highest prevalence of HAI in
the ICU at 23%. Other previous studies in Nigeria reported a prevalence of 15% [12,
13] and 11.8% [16, 17] his can be attributed to a more susceptible patient population,
use of broad-spectrum antimicrobial agents and frequent use of invasive devices in
an ICU setting.
The findings of UTI as the most common type of HAI is in keeping with the re-
ported figure of 43.9% in a previous study in Nigeria [17] and 48.2% in the Benin
Republic [18]. However, a point prevalence study in Ethiopia, as well as a system-
atic review in sub-Saharan African countries comprising mostly studies from surgi-
cal wards, reported SSI as the most prevalent HAI [19, 20]. Similarly, in this study,
most of the SSI and skin and soft tissue infections occurred in the surgical ward.
Contrary to reports from other studies [21, 22], pneumonia and blood stream infec-
tions did not feature prominently in this study, likely because of infrequent use of
central intravenous catheters and mechanical ventilators, making urinary catheters
the most commonly used invasive device and hence the high prevalence of UTI
[22,23,24]. Therefore, infection control programs in our health care facilities must
implement and monitor strategies to limit catheter-acquired urinary infection,
including surveillance of catheter use, appropriateness of catheter indications, and
complications.
As in several other studies in Nigeria, gram-negative rods were the most frequent
isolates in this study. Although E. coli was the most frequent isolate in our hospital
Afolabi et al., [12] and Ige et al., [17] reported K. pneumonia, while Onipede et al.,
[13] reported P. aeruginosa as the most frequent isolates. This finding is not surpris-
ing as gram-negative rods have been commonly associated with HAIs [25, 26]. S.
aureus was also the most frequent isolates in the skin and soft tissue infection and
SSI, similar to other studies in Nigeria [12, 13, 17]. This is also similar to the findings
in Brazil [27], India [28], Taiwan [29], Ethiopia [30], and the United States [31]. We
found only 2 (0.04%) cases of S. pneumoniae associated HAI, with one been SSI. In
agreement with this finding S. pneumoniae has been reported to be a rare cause of
HAI, and rarely cause SSI. In fact, the first case of SSI caused by S. pneumoniae
was only reported in 1994 [32, 33].
Although extended-spectrum beta-lactamase (ESBL) testing was not routine in
our hospital during the study period, high rate of resistance among theon.2018.e00720
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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observed. Therefore this suggests the probable high burden of ESBL pathogens
in our hospital. The rate of S. aureus isolates resistant to cloxacillin was alarming
and suggests a high burden of MRSA. Previously in the same hospital, we reported
a high prevalence of cloxacillin resistant S. aureus and gram-negative rods resistant
to third-generation cephalosporin [16, 34]. This pattern of resistance is also similar
to what has been reported by Ohoye et al. in the Benin Republic [18]. The avail-
ability of all classes of antibiotic as over the counter drugs in Nigeria has fueled
misuse of these drugs among the public. This coupled with the inappropriate use
of antibiotics in our hospitals due to lack of antibiotic stewardships program in
most of these hospitals, may be directly connected to the pattern of resistance
seen in this study as well as other studies in Nigeria. High cost and unavailability
of the carbapenems and colistin in Nigeria means these drugs are out of reach of
most patients, hence, less likely to be abused. Therefore, this explains the excellent
sensitivity of meropenem and colistin seen in this study. Of note chloramphenicol
which is an old and cheap drug showed relatively good sensitivity profile among all
the isolates. This is likely because of a decline in the rate of misuse of chloram-
phenicol following the emergence of MDR salmonella and availability of cheaper
generic quinolones.
Giving the retrospective nature of the study and limited infection control resources
in our hospital, it is likely that the actual burden of HAI may have been substan-
tially underestimated. Also, HAI that developed after hospital discharge would
have been missed. Lack of routine screening for MRSA, Vancomycin Resistant
S. aureus (VRSA), Vancomycin Resistant Enterococci (VRE) and extended-
Spectrum beta-Lactamases is another limitation. However, high prevalence of clox-
acillin resistant S. aureus and gram-negative rods resistant to third generation ceph-
alosporin indirectly reflect the high burden of MRSA and ESBL producing
Enterobacteriaceae respectively. Length of hospital stay and some co-morbidities
that are important risk factors for HAI were not captured. It is also unclear whether
the findings of this single center study are generalizable nation wide. Despite these
limitations, our study presents detailed assessment of the burden of HAI in north-
west Nigeria that will serve as a useful reference for surveillance and monitoring
trends.
Previously, we have reported on the poor infection control practices in our hospital
[35]. This is further confounded by overcrowding in hospitals with relatives having
to take up temporary residence in the hospital to provide food, care, and comfort,
therefore, impeding interruption of HAI transmission [36, 37]. Hence we strongly
recommend policy change in the hospital to impose implementation of ICP proto-
col. Both at the local and national level, there is a need for antibiotic policy. Even-
tually, this may lead to having an effective antibiotic stewardship program in our
hospitals.on.2018.e00720
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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The findings of this study highlight the high burden of HAI especially UTI in our
hospital with resistance to commonly used antibiotics also documented. This is a
cause for concern considering the unavailability and high cost of the alternative an-
tibiotics in this resource-limited country. There is a need for effective antibiotic stew-
ardship program in our hospitals and prospective nationwide HAI surveillance to
monitor the burden and trends of HAI in Nigeria.Declarations
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